Investors Research Corp’s BlackRock Health Sciences Trust BME Stock Holding History

Investors Research Corp’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.62K	Hold	150	–	–	﹤0.01%	574
2026 Q2	$6.44K	Hold	150	–	–	﹤0.01%	577
2026 Q1	$5.78K	Hold	150	–	–	﹤0.01%	594
2025 Q4	$6.17K	Hold	150	–	–	﹤0.01%	663
2025 Q3	$5.58K	Hold	150	–	–	﹤0.01%	706
2025 Q2	$5.47K	Buy	+150	New	+$5.44K	﹤0.01%	736

Other funds holding BME

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

CFSG

Community Financial Services Group Newport, Vermont $655M AUM 21.88% 1-Year Est. Return

Investors Research Corp's BME Position: Q3 2026 in Review

Investors Research Corp held its BlackRock Health Sciences Trust (BME) position steady in Q3 2026 at 150 shares worth $6.62K. The position accounts for ﹤0.01% of the portfolio, ranked #574.

Investors Research Corp first reported a position in BME in Q2 2025 and has held it in 6 quarters since. 4 funds tracked by Wall St. Rank hold BME as of Q3 2026.

Investors Research Corp held 150 shares of BlackRock Health Sciences Trust worth $6.62K as of Q3 2026.
Investors Research Corp left its BlackRock Health Sciences Trust share count unchanged in Q3 2026.
BlackRock Health Sciences Trust made up ﹤0.01% of Investors Research Corp's portfolio in Q3 2026, its #574 holding.
Investors Research Corp first reported a position in BlackRock Health Sciences Trust in Q2 2025 and has held it in 6 quarters since.
4 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.